Tag: VERS
Semaglutide Not Linked to Increased Risk of Eye Disorders, Diabetic Retinopathy
Semaglutide linked to increased risk of nonarteritic anterior ischemic optic neuropathy, but evidence remains insufficient to establish definitive conclusion
COVID-19 mRNA Vaccine Targeting Omicron JN.1 Lineage Safe
No significant increases seen in rate of hospital contacts for any of 29 adverse events in 28-day risk period after vaccination
GLP-1 Receptor Agonist Use Linked to Nonarteritic Anterior Ischemic Optic Neuropathy
Association seen in seniors with type 2 diabetes; greater associations seen for semaglutide and liraglutide
Glipizide Linked to Highest MACE-4 Risk in Individuals With Type 2 Diabetes
Highest risk seen with glipizide versus other sulfonylureas and DPP4 inhibitors as second-line therapy
Standardization Needed for Dialysis Initiation in Pregnancy
Women who started dialysis during pregnancy more often had adverse maternal and fetal outcomes
GLP-1 Receptor Agonist Use in T2D Tied to Increased Risk for GERD, GERD Complications
Risk ratios were 1.27 and 1.55 for GERD and its complications during a median follow-up of three years for GLP-1 RA versus SGLT-2 inhibitor users
Many Ineligible for Clinical Trial Could Benefit From Teclistamab for Multiple Myeloma
89 percent of 509 patients would have been ineligible for MajesTEC-1 trial; estimated median PFS was 5.8 months
Anticholinergics Tied to Physical Performance Decline in Older Adults
Authors say findings support guidance to avoid these medications when possible
Gabapentin for Back Pain Linked to Increased Risk for Dementia, MCI
Further increase in risk was seen with prescription frequency, with higher risk for 12 or more prescriptions
Increased Liver Enzyme Levels Seen With Use of Cannabidiol in Adults
Cannabidiol within the range consumers are taking with unregulated products linked to increase in liver enzymes
